학술논문
Ind-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system
Document Type
Article
Author
Puig-Saus, C.; Parisi, G.; Garcia-Diaz, A.; Krystofinski, P.E.; Sandoval, S.; Zhang, R.; Champhekar, A.S.; McCabe, J.; Cheung-Lau, G.C.; Truong, N.A.; Vega-Crespo, A.; Komenan, M.D.S.; Pang, J.; Macabali, M.H.; Saco, J.D.; Seet, C.S.; Nguyen, A.; Cabrera, P.; Kaplan-Lefko, P.J.; Berent-Maoz, B.; Ribas, A.; Crooks, G.M.; Yang, L.; Comin-Anduix, B.; Goodwin, J.L.; Bolon, B.; Montel-Hagen, A.; Adelson, C.; Witte, O.N.; Hollis, R.P.; Campo-Fernandez, B.; Gschweng, E.H.; Kohn, D.B.; Bischof, D.; Cornetta, K.; Baltimore, D.; Wang, X.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 February 2019, 25(3):1000-1011)
Subject
Language
English
ISSN
15573265
10780432
10780432